MyHomeDoctor - Suivi des patients après une chirurgie ambulatoire

The latest studies inserted

Kusajili is updated regularly with data from the following sources: ACTRN, EU Clinical Trials Register, GlaxoSmithKline (GSK) Clinical Study Register, Clinical Trials Search Portal provides, ISRCTN, JPRN, ClinicalTrials - NCT, Pfizer, Takeda, Pubmed.

Spotlight on 3 studies

Regularly we prefer 3 studies to help the inclusion of patients.

Liposomal Irinotecan and Veliparib in Treating Patients With Solid Tumors

This phase I trial studies the side effects and best dose of veliparib when given together with liposomal irinotecan in treating patients with solid tumors. Liposomal irinotecan and veliparib may stop the growth of tumor cells by blocking some of the enzymes needed for cell growth.

More information

HDAC Inhibitor AR-42 and Pomalidomide in Treating Patients With Relapsed Multiple Myeloma

This pilot phase I trial studies the side effects and best dose of histone deacetylase (HDAC) inhibitor AR-42 (AR-42) when given together with pomalidomide in treating patients with multiple myeloma that has returned after a period of improvement. HDAC inhibitor AR-42 may work to stop cancer growth by blocking an enzyme needed for cell growth. Pomalidomide is a drug used in...

More information

VX-970, Cisplatin, and Radiation Therapy in Treating Patients With Locally Advanced HPV-Negative Head and Neck Squamous Cell Carcinoma

This phase I trial studies the side effects and best dose of ATR kinase inhibitor VX-970 (VX-970) when given together with cisplatin and radiation therapy in treating patients with human papillomavirus negative (HPV) (-) head and neck squamous cell carcinoma that has spread from where it started to nearby tissue or lymph nodes. ATR kinase inhibitor VX-970 may stop the growt...

More information

KUSAJILI ?

Kusajili is a protean search engine that addresses the need to simplify access to registers and patient inclusions.
Kusajili makes it possible to find in a few clicks, the numerous French and international trials referenced.
Kusajili, associated with MyHomeDoctor, facilitates multicenter clinical trials.
Docteur CRETON, Créateur de KUSAJILI

More information